Bibliographic Details
| Title: |
Phase 3 Randomized, Multicenter, Placebo-Controlled Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of an Adjuvanted Cell Culture-Derived, H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects |
| Authors: |
James Peterson, Esther Van Twuijver, Eve Versage, Matthew Hohenboken |
| Source: |
Vaccines, Vol 10, Iss 4, p 497 (2022) |
| Publisher Information: |
MDPI AG, 2022. |
| Publication Year: |
2022 |
| Collection: |
LCC:Medicine |
| Subject Terms: |
influenza, vaccine, cell culture-derived, H5N1, pandemic, adult, Medicine |
| More Details: |
A cell-based process may be better suited for vaccine production during a highly pathogenic avian influenza (HPAI) pandemic. This was a phase 3, randomized, controlled, observer-blind, multicenter study evaluated safety, immunogenicity, and lot-to-lot consistency of two doses of a MF59-adjuvanted, H5N1 influenza pandemic vaccine manufactured on a cell culture platform (aH5N1c) in 3196 healthy adult subjects, stratified into two age groups: 18 to |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
2076-393X |
| Relation: |
https://www.mdpi.com/2076-393X/10/4/497; https://doaj.org/toc/2076-393X |
| DOI: |
10.3390/vaccines10040497 |
| Access URL: |
https://doaj.org/article/b71bd519244448a5bd91b85e1a6f7404 |
| Accession Number: |
edsdoj.b71bd519244448a5bd91b85e1a6f7404 |
| Database: |
Directory of Open Access Journals |
